Douglas Lowy has been named the acting director of the US National Cancer Institute, the National Institutes of Health has announced.

Lowy, who received the National Medal of Technology and Innovation in 2014 for his work that led to the development of the human papillomavirus vaccine, has served as the deputy director of the institute since July 2010.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.